N/A
Completed N=21
Investigation of a New Diet for the Treatment of Obesity in the NHS
Source: ClinicalTrials.gov NCT05249439 ↗Enrolled (actual)
21
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcomePrimary: Body Weight Change — -12.99 kg — p=<0.0001
Summary
Over one in four adults living in the UK is living with obesity. Obesity is associated with health complications including type 2 diabetes, heart disease and depression. The current NHS treatment for obesity includes attending a specialist hospital weight management service called 'Tier 3' where patients receive help from healthcare professionals such as doctors, dieticians and psychologists. It is known that health conditions associated with obesity improve or reverse if a person with obesity loses five per cent or more of their body weight. On average, currently available Tier 3 programmes achieve less weight loss than this. In our specialist obesity clinic at the Imperial Weight Centre, we (the study research team) have designed a new weight loss programme called Imperial Satiety Protocol (or I-SatPro for short). I-SatPro comprises dietary advice including eating a low carbohydrate (low glycaemic index) diet, eating protein for the satiating effects, eating healthy fats and abstaining from high sugar and/or processed foods which can drive over-eating. Participants will be advised to eat according to subjective feelings of hunger and fullness, rather than eating according to a defined calorie restriction. Similar to other Tier 3 Programmes, I-SatPro also contains locally devised content related to healthy eating, for example fibre intake, the timing of eating, lifestyle change such as exercise, self-care such as advice on sleep and behavioural change strategies.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Body Weight Change |
-12.99 | <0.0001 sig |
| SECONDARY Energy Expenditure (How Efficiently Your Body Burns Calories) |
17.8; 17.7; 18.0 | — |
| SECONDARY Body Weight Composition - How Much of Your Weight is Body Fat? |
43.8; 48.7 | — |
| SECONDARY Change in Blood Pressure |
-6.0 | — |
| SECONDARY Change in Blood Sugar Levels (Changes in the Blood Test Marker for Diabetes Called HbA1c) |
-1.3 | — |
| SECONDARY Measurement of Eating Patterns, Hunger Levels and Relationship With Food |
8.4; 6.8; 0.7; 10.0; 9.7; 10.4 | — |
| SECONDARY Change in Scores Across the Three Measured Domains (Emotional Eating, External Eating and Restrained Eating) on Dutch Eating Behaviours Questionnaire (DEBQ) |
27.3; 32.8; 33.4; 53.3; 35.8; 28.3 | — |
| SECONDARY Measurement of Wellbeing and Quality of Life |
70.0; 45; 98.6; 53.6; 25.0; 100 | — |
| SECONDARY Patient Drop-out Rate |
2; 5 | — |
Eligibility Criteria
Inclusion Criteria
- Aged ≥18 years
- Male or female
- Body mass index ≥35kg/m2 with at least one obesity related co-morbidity
- Body mass index ≥40kg/m2 with or without an obesity related co-morbidity
- Eligible for treatment under the NHS
Exclusion Criteria
- History of any medical, psychological or other condition, or use of any medications, which would either compromise the validity of the study or the safety of the participant
- English language fluency and comprehension insufficient to be able to participate in educational and group components of the programme
- Usual residence/place of work is sufficiently far from the study site or logistical/lifestyle factors mean that it is likely that the patient would be unable to attend for all sessions/components of the study
- Pregnancy or breast feeding
- Previous bariatric surgery
- Concurrent participation in another research study which would either compromise the validity of the study or the safety of the participant
- Previous participation in a study if the investigators judge that this would either compromise the validity of the study or the safety of the participant
- Unable to give informed consent
Data sourced from ClinicalTrials.gov (NCT05249439). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.